↓ Skip to main content

Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer

Overview of attention for article published in Breast Cancer Research, January 2012
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
107 Dimensions

Readers on

mendeley
63 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer
Published in
Breast Cancer Research, January 2012
DOI 10.1186/bcr3084
Pubmed ID
Authors

Mohammed A Aleskandarany, Andrew R Green, Ahmed A Benhasouna, Fabricio F Barros, Keith Neal, Jorge S Reis-Filho, Ian O Ellis, Emad A Rakha

Abstract

Although the prognostic significance of proliferation in early invasive breast cancer has been recognized for a long time, recent gene-expression profiling studies have reemphasized its biologic and prognostic value and the potential application of its assessment in routine practice, particularly to define prognostic subgroups of luminal/hormone receptor-positive (HR+) tumors. This study aimed to assess the prognostic value of a proliferation assay by using Ki-67 immunohistochemistry as compared with mitotic count scores.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 63 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 2%
Mexico 1 2%
Turkey 1 2%
Serbia 1 2%
Unknown 59 94%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 9 14%
Student > Postgraduate 7 11%
Student > Bachelor 7 11%
Student > Doctoral Student 7 11%
Researcher 5 8%
Other 11 17%
Unknown 17 27%
Readers by discipline Count As %
Medicine and Dentistry 27 43%
Biochemistry, Genetics and Molecular Biology 4 6%
Agricultural and Biological Sciences 4 6%
Immunology and Microbiology 2 3%
Nursing and Health Professions 2 3%
Other 2 3%
Unknown 22 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 January 2012.
All research outputs
#20,655,488
of 25,371,288 outputs
Outputs from Breast Cancer Research
#1,705
of 2,052 outputs
Outputs of similar age
#200,726
of 246,767 outputs
Outputs of similar age from Breast Cancer Research
#40
of 46 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,052 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.2. This one is in the 8th percentile – i.e., 8% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 246,767 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 8th percentile – i.e., 8% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 46 others from the same source and published within six weeks on either side of this one. This one is in the 4th percentile – i.e., 4% of its contemporaries scored the same or lower than it.